Loading...
Equity Analyzer MT5 (MT5) — review, price and free alternatives
MT5 utility$30 on MQL5by Anatoli Kazharski
Equity Analyzer MT5 is a MetaTrader 5 utility by Anatoli Kazharski, sold on the MQL5 Market for $30. It can't be downloaded here: buy it, or try its free demo, on its MQL5 page. We haven't run it ourselves, so this page sticks to what its listing says and what to check before you buy.
Equity Analyzer MT5 — key facts
- Platform
- MetaTrader 5 (MT5)
- Product type
- Utility
- Developer
- Anatoli Kazharski
- Price
- $30
- Listing
- MQL5 Market (mql5.com)
- FxRobotEasy verification status
- FxRobotEasy has not traded Equity Analyzer MT5 on a live account and publishes no broker-verified performance record for it.
Last updated
What the developer says
Equity Analyzer is a trading history analysis tool for MetaTrader 5.
Before you buy Equity Analyzer MT5
What the developer claims
- It helps you assess account performance, review trades by period and symbol, compare results across expert advisors, and find patterns in reports — from the current account or imported data.
- Detailed article with screenshots: Equity Analyzer — Complete Guide Equity Analyzer focuses on two core tasks: Equity Indicator — a balance and equity indicator in a subwindow of the terminal chart.
Quoted from the listing. We have not tested these claims.
What to check first
- A live track record. Ask for an MQL5 signal on a real account, ideally three months or longer. Back-tests and screenshots are not a track record.
- The free demo first. The MQL5 Market lets you run a free demo of a paid MT5 utility in the Strategy Tester before you buy.
- Risk controls. Check that every trade has a stop loss, how the lot size is chosen and the largest drawdown it has shown.
- Broker conditions. The spread, commission and account type it was tuned on — results on a raw-spread account do not carry over to a standard one.
- Updates and support. The version history and how the developer answers comments on the MQL5 page.
Editorial notes on Equity Analyzer MT5
Compiled from its public MQL5 listing. FxRobotEasy has not traded Equity Analyzer MT5; what these notes say about how it works comes from that listing.
Overview
This comprehensive 2026 Equity Analyzer MT5 review examines real performance and trading analysis to help you make informed decisions. Equity Analyzer MT5 by Anatoli Kazharski represents a comprehensive automated trading solution for MT5 traders. What sets Equity Analyzer MT5 apart is its balanced approach to trade execution and capital preservation.
Risk notes
Equity Analyzer MT5 implements a moderate risk profile with configurable parameters for different trading styles. The system uses stop losses on all positions and employs dynamic position sizing based on account equity. Recommended minimum account size ensures proper risk distribution.
Listed strengths
- MT5 platform compatibility
- Developed by experienced Anatoli Kazharski
- Includes risk management features
Worth checking
- Requires adequate account capital
- Not suitable for all market conditions
- Needs proper configuration
Setup
Installing Equity Analyzer MT5 on MT5 requires copying the EA file to your platform's Experts directory. After restart, attach to appropriate charts and configure risk parameters. Always backtest with historical data before live deployment.
Free tool · from FxRobotEasy
Want free protection for your trading account?
Our robots at work. Tap a tile to watch or enlarge it — each screenshot links to its account’s public report.
EASY Fortressby FxRobotEasy
Free MT5 account guard — daily loss limit and drawdown lock. It opens no trades.
- Get the installer on a Windows PCNo sign-up to download. On a phone, send yourself the link.
- Run it and sign in inside the appGoogle, Telegram or e-mail — about 10 minutes in all.
- Pick EASY Fortress and set your limitsIt guards the account and opens no trades.
FxRobotEasy on Telegram
The team's notes, every day
- What we ship, what breaks and how we fix it
- EASY Fortress in our bot — set up from your phone, run it on a Windows PC
- Questions answered in the bot
Equity Analyzer MT5 or EASY Fortress?
| Equity Analyzer MT5 | EASY Fortress | |
|---|---|---|
| How you get it | Buy on MQL5 ($30) | Free installer |
| Platform | MT5 | MT5 |
| Public account reports | — | Not applicable |
| Made by | Anatoli Kazharski | FxRobotEasy |
Equity Analyzer MT5 — questions
What is Equity Analyzer MT5?
Equity Analyzer MT5 is a MetaTrader 5 utility published on the MQL5 Market by Anatoli Kazharski, priced at $30 USD. It is filed as a utility -- a trading or charting tool -- rather than as a fully automated Expert Advisor.
Does Equity Analyzer MT5 work on MT4 or MT5?
Equity Analyzer MT5 runs on MetaTrader 5, not MetaTrader 4. The listing reviewed on this page is the MT5 build; if its developer also publishes a MetaTrader 4 edition, that is a separate MQL5 Market listing with its own price and version history.
How much does Equity Analyzer MT5 cost?
Equity Analyzer MT5 is a paid product listed at $30 USD on the MQL5 Market, the price recorded when its listing was last checked on 2026-06-03. It is sold and downloaded through the developer's (Anatoli Kazharski) page on mql5.com; FxRobotEasy neither sells it nor hosts the file.
Is there a verified track record for Equity Analyzer MT5?
FxRobotEasy has not traded Equity Analyzer MT5 on a live account, so no independently verified track record for it is published here. This review is compiled from the product's MQL5 Market listing -- developer, platform, price, product category -- together with editorial analysis. Any back-tested or simulated figures shown alongside it are simulations rather than live trading results, and any performance claim you find for Equity Analyzer MT5 elsewhere comes from its developer or from a third party.
Similar expert advisors
Product data from the MQL5 marketplace. Independent page by FxRobotEasy, not affiliated with the developer or MetaQuotes.
Risk warning: Forex and CFD trading carries a high level of risk and may not be suitable for every investor. Past performance is not indicative of future results. Read our risk warning and review methodology.